An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer

BACKGROUND: Patients with small-cell lung cancer (SCLC) are burdened by limited treatment options and the disease’s dismal prognosis. Long non-coding RNAs (lncRNAs) are essential regulators of genetic alteration and are actively involved in tumor immunity. However, few studies have examined interact...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhihui, Luo, Yuejun, Zhang, Chaoqi, Wu, Peng, Zhang, Guochao, Zeng, Qingpeg, Wang, Lide, Xue, Liyan, Yang, Zhaoyang, Zeng, Hua, Zheng, Bo, Tan, Fengwei, Xue, Qi, Gao, Shugeng, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691030/
https://www.ncbi.nlm.nih.gov/pubmed/34930244
http://dx.doi.org/10.1186/s12935-021-02357-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691030/
https://www.ncbi.nlm.nih.gov/pubmed/34930244
http://dx.doi.org/10.1186/s12935-021-02357-1

Ejemplares similares